LRI Investments LLC Has $875,000 Position in Intuitive Surgical, Inc. $ISRG

LRI Investments LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.6% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,610 shares of the medical equipment provider’s stock after purchasing an additional 377 shares during the quarter. LRI Investments LLC’s holdings in Intuitive Surgical were worth $875,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in ISRG. Brighton Jones LLC lifted its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares in the last quarter. GAMMA Investing LLC raised its stake in Intuitive Surgical by 9.3% in the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock worth $3,029,000 after purchasing an additional 518 shares in the last quarter. Stanley Laman Group Ltd. raised its stake in Intuitive Surgical by 38.9% in the 1st quarter. Stanley Laman Group Ltd. now owns 868 shares of the medical equipment provider’s stock worth $430,000 after purchasing an additional 243 shares in the last quarter. West Branch Capital LLC raised its stake in Intuitive Surgical by 31.5% in the 1st quarter. West Branch Capital LLC now owns 685 shares of the medical equipment provider’s stock worth $339,000 after purchasing an additional 164 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC raised its stake in Intuitive Surgical by 16.1% in the 1st quarter. Elevation Point Wealth Partners LLC now owns 562 shares of the medical equipment provider’s stock worth $278,000 after purchasing an additional 78 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ISRG. The Goldman Sachs Group dropped their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. BTIG Research reiterated a “buy” rating and issued a $571.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Price Performance

Shares of ISRG opened at $429.59 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a market cap of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61. The firm has a 50 day simple moving average of $458.68 and a two-hundred day simple moving average of $497.91.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the previous year, the firm earned $1.78 EPS. Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.